152 related articles for article (PubMed ID: 30916804)
1. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
2. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
[TBL] [Abstract][Full Text] [Related]
5. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.
Mitterlechner T; Fiegl M; Mühlböck H; Oberaigner W; Dirnhofer S; Tzankov A
J Clin Pathol; 2006 Jan; 59(1):48-55. PubMed ID: 16394280
[TBL] [Abstract][Full Text] [Related]
7. Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
Yu N; Zhang W; Zhong X; Song X; Li W
PLoS One; 2024; 19(3):e0300330. PubMed ID: 38466704
[TBL] [Abstract][Full Text] [Related]
8. Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1074-1078. PubMed ID: 32108027
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
[TBL] [Abstract][Full Text] [Related]
10. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
[TBL] [Abstract][Full Text] [Related]
11. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.
Li X; Gao F; Meng X; Zhang X; Sun C; Liu H; Yu J; Liu X; Han X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Golchehre Z; Chavoshzadeh Z; Ren X; Wang X; Zhang H
Br J Haematol; 2024 May; 204(5):1771-1779. PubMed ID: 38447995
[TBL] [Abstract][Full Text] [Related]
13. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
[TBL] [Abstract][Full Text] [Related]
14. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.
Yanik EL; Shiels MS; Smith JM; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
Cancer; 2017 Dec; 123(23):4663-4671. PubMed ID: 28759103
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Morton LM; Wang SS; Devesa SS; Hartge P; Weisenburger DD; Linet MS
Blood; 2006 Jan; 107(1):265-76. PubMed ID: 16150940
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
18. Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century.
Bei LY; Shang CY; Wu JZ; Shen HR; Yin H; Liang JH; Zhang XY; Wang L; Li JY; Li Y; Xu W
Ann Hematol; 2024 May; 103(5):1675-1685. PubMed ID: 38228775
[TBL] [Abstract][Full Text] [Related]
19. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.
Kane EV; Bernstein L; Bracci PM; Cerhan JR; Costas L; Dal Maso L; Holly EA; La Vecchia C; Matsuo K; Sanjose S; Spinelli JJ; Wang SS; Zhang Y; Zheng T; Roman E; Kricker A;
Ann Oncol; 2013 Feb; 24(2):433-441. PubMed ID: 22967995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
